May. 12 at 8:36 PM
$PEPG - PepGen Inc - 10Q - Updated Risk Factors
🚨 Peer Alert: Risk-factor words are +377.1% above peer average (55,820 vs 11,699 across 653 peers).
PEPG’s 10-Q sharpens downside risk: it is now essentially a single‑asset, early‑stage biotech (PGN‑EDODM1 on partial FDA hold) with no revenue, escalating losses, heavy future financing needs, unproven platform, major safety and regulatory uncertainty, and a fragile, license‑dependent IP position vulnerable to challenges and enforcement failures.
🟢 Added 🟠 Removed
https://d-risk.ai/PEPG/10-Q/2026-05-12
